Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Other Countries by Year
Other Countries ($M)
Novartis Other Countries: $21,684M in FY2025, up 6.8% from a year earlier.
Latest, FY2025
21,684
Period ended Dec 31, 2025
Change on a year earlier
+6.8%
20,306 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Countries ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21,684 | +6.8% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 20,306 | +3.9% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 19,539 | +12.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 17,432 | +7.1% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 16,274 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up other Countries
Cite this data
StockData. (2026). Novartis Other Countries ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-country-other-annual
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.